Real-World Data for Clinical Research
Real-time access to clinical data from the largest global network of healthcare organizations
Webinar Event
Leveraging A Medical Record-Enriched Patient Dataset for COVID-19 Research
Watch On-Demand
TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research easier and more efficient.
Optimize Clinical Research
Generate Real-World Evidence
Collaborate on Clinical Trials
Longitudinal Real-World Data
Real-time access to patient populations, driven and refreshed by electronic medical record (EMR) data, to determine protocol feasibility, cohort analysis, site identification and the generation of real-world evidence to support regulatory submissions.
Data Linking
Demographics
Diagnoses
Genomics
Lab Results
Longitudinal Patient History
Medications
Mortality
Oncology
Patient Location
Procedures
Provider Notes (NLP)
Tumor Registry
Vitals
Highly Intuitive Analytics
Quickly gain real-world insights into how patients are treated and their outcomes or conduct full-protocol driven observational research studies in a fraction of the usual time.
Global and Diverse Healthcare Research Network
Conduct region-specific studies compliant with local privacy regulations in over 30 countries.
Case Study: The West Virginia Clinical and Translational Science Institute (WVCTSI)
Enhancing Research Studies, Increasing ClinicalTrial Opportunities at West Virginia Clinical and Translational Science Institute (WVCTSI)
Clinical Data for COVID-19 Research
Counts of possible COVID-19 patients based on a combination of ICD-10 diagnostic terms and confirmatory laboratory results occurring on or after January 20, 2020, as of November 24, 2020.
Better understand the risk factors, comorbidities and outcomes of COVID-19 patients
Recent Scientific Publications
Singh S, Khan A, Chowdhry M, Bilal M, Kochhar GS, Clarke K, Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study., Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.06.003.
Turk M, Landes S, Formica M, Goss K, Intellectual and developmental disability and COVID-19 case fatality trends: TriNetX analysis., Disability and Health Journal (2020), doi: https://doi.org/10.1016/j.dhjo.2020.100942.
Open Source from TriNetX
TriNetX believes in community involvement and the democratization of software tools. Open.TriNetX is our open source contribution to empowering the global research community. Our OPS to SNOMED CT Mapping solution is the beginning of what we plan to be a growing library of open source content, tools, and solutions.
News
TriNetX Recognized by Deloitte as One of the Fastest-Growing Companies in North America
Cambridge, MA, November 19, 2020 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced it has placed on Deloitte’s Technology Fast 500™, a...
Narayana Health in India Joins the TriNetX Network to Drive Innovation and Attract Global Clinical Trials
Narayana Health, headquartered in Bengaluru, India, has joined the TriNetX global health research network to help increase access to data that can drive innovation and expose them to more locally relevant global clinical trials.
UAE’s Mediclinic Middle East Joins the TriNetX Network to Expand Clinical Research Opportunities
Mediclinic Middle East, located in Dubai, Al Ain, and Abu Dhabi in the United Arab Emirates (UAE), has joined the TriNetX network to help grow the hospital group’s overall research portfolio and expand its clinical trial opportunities.
#TriNetX is proud to be recognized by @DeloitteTMT as one of the fastest growing companies in North America #Fast500
https://bit.ly/2HgNtrL
.@MediclinicME in #UAE joins the #TriNetX global health research network to expand clinical research opportunities. https://bit.ly/38xUW0T #clinicaltrials
20% of #COVID19 patients receive a psychiatric diagnosis within 90 days - new study published in @TheLancetPsych shows. https://oxfordhealthbrc.nihr.ac.uk/covid-19-patients-receive-psychiatric-diagnosis/ @NIHRresearch @NIHRCRN_tvsm
New study by @UniofOxford researchers published in @TheLancetPsych using #EMR data finds 1 in 5 #COVID19 patients receive psychiatric diagnosis w/in 90 days; finds patients w/ existing psychiatric disorders more likely to contract #coronavirus. #RWD
https://bit.ly/2IoBOYe
@kmdsilvaMD @MGHMedicine presents data from TriNetX EHR
Patients with rheumatic disease might be at increased risk of severe #COVID19 outcomes compared to the general population, but this is mitigated by adjustment for comorbidities, and the risk has reduced over time! #ACR20
